Concepedia

Maximilian Richter

MR

6

Publications

147

Citations

6

H-Index

2012

Active since

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

Compliment Corporation (United States)

University of Washington Medical Center

Maximilian Richter is an author at University of Washington specializing in humoral immunity, immune regulation, and drug discovery.

ORCID

Top concepts

Publications per year

2012–2022

6

Publications

6

Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs

Ines Beyer, Hua Cao, Jonas Persson et al. · Clinical Cancer Research · 2012 · 62 citations

Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin

Maximilian Richter, Roma Yumul, Hongjie Wang et al. · Molecular Therapy — Methods & Clinical Development · 2015 · 28 citations · Full text

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

Maximilian Richter, Roma Yumul, Kamola Saydaminova et al. · Molecular Therapy — Methods & Clinical Development · 2016 · 16 citations · Full text

, , +23

The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases

Christian Doll, Claudius Steffen, Benedicta Beck‐Broichsitter et al. · Anticancer Research · 2022 · 15 citations

Manufacture of an Allogeneic CAR-T Stem Cell Memory Product Candidate for Multiple Myeloma, P-Bcma-ALLO1, Is Robust, Reproducible and Highly Scalable

Stacey Cranert, Maximilian Richter, Min Tong et al. · Blood · 2019 · 14 citations

Rows per page

1–5 of 6